Biostate AI: $12 Million Raised For AI And RNA Sequencing Platform
By Amit Chowdhry ● May 26, 2025
Biostate AI, an innovator in AI and RNA sequencing, announced the completion of a $12 million Series A funding round, led by Accel. And additional investors included Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. The company's seed funding round also saw participation from notable angel investors, including Dario Amodei (CEO, Anthropic), Mike Schnall-Levin (CTO, 10x Genomics), and Emily Leproust (CEO, Twist Bioscience).